Literature DB >> 24248893

Temporal trends of incidence and survival of sarcoma of digestive tract including Gastrointestinal Stromal Tumours (GIST) in two areas of the north-east of Spain in the period 1981-2005: a population-based study.

J Rubió-Casadevall1, J L Borràs, C Carmona, A Ameijide, G Osca, L Vilardell, A Izquierdo, J Galceran, R Marcos-Gragera.   

Abstract

INTRODUCTION: The diagnostic approach of Gastrointestinal Stromal Tumours (GIST) was established in 2002. Before this, GIST had been classified with a wide range of histological terms. This fact and the consideration of potential malignity of all these tumours led to a false perception of an increasing incidence.
PURPOSE: This study aimed at evaluating the accuracy in registration of sarcoma of digestive tract and GIST and to elucidate the trends of incidence and survival of those.
MATERIALS AND METHODS: We used data from two population-based cancer registries in Spain. In the Girona's Cancer Registry we previously reclassified all sarcoma of digestive tract performing c-kit to confirm GIST and analysed the time period 1994-2005. In Tarragona's Cancer Registry, where we analysed the time period 1981-2005, this reclassification was not done.
RESULTS: We obtained a significant increasing trend in incidence of all sarcoma of digestive tract in the Tarragona Cancer Registry database, with an annual per cent of change of 3.87 but a non-statistically significant trend in incidence in the Girona Cancer Registry database. The incidence of GIST in Girona Cancer Registry was 1.24 cases/100,000 inhabitants/year. Survival rates did not change in time and was high in less aggressive GIST. The 5-year relative survival for low, intermediate and high risk of malignant behaviour GIST groups were, respectively, 80.5, 85.6 and 64.6 %.
CONCLUSIONS: The increase in the incidence of GIST could be explained by the improvement in their diagnosis and registration. The survival of low and intermediate risk of malignant behaviour is high and close to normal population survival.

Entities:  

Mesh:

Year:  2013        PMID: 24248893     DOI: 10.1007/s12094-013-1131-0

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  16 in total

1.  Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.

Authors:  Markku Miettinen; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2005-01       Impact factor: 6.394

2.  Relative survival and the estimation of net survival: elements for further discussion.

Authors:  J Estève; E Benhamou; M Croasdale; L Raymond
Journal:  Stat Med       Date:  1990-05       Impact factor: 2.373

3.  Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of northern Norway.

Authors:  Sonja Eriksson Steigen; Tor J Eide
Journal:  APMIS       Date:  2006-03       Impact factor: 3.205

Review 4.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

5.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

Authors:  S Hirota; K Isozaki; Y Moriyama; K Hashimoto; T Nishida; S Ishiguro; K Kawano; M Hanada; A Kurata; M Takeda; G Muhammad Tunio; Y Matsuzawa; Y Kanakura; Y Shinomura; Y Kitamura
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

6.  Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004.

Authors:  Mee-Yon Cho; Jin Hee Sohn; Joon Mee Kim; Kyoung-Mee Kim; Young Su Park; Woo Ho Kim; Jin Sook Jung; Eun Sun Jung; So-Young Jin; Dae Young Kang; Jae Bok Park; Ho Sung Park; You Duck Choi; Sun Hee Sung; Young-Bae Kim; Hogeun Kim; Young-Kyung Bae; Miseon Kang; Hee Jin Chang; Yang Seok Chae; Hee Eun Lee; Do Youn Park; Youn Soo Lee; Yun Kyung Kang; Hye Kyung Kim; Hee-Kyung Chang; Soon Won Hong; Young Hee Choi; Okran Shin; MiJin Gu; Youn Wha Kim; Gwang Il Kim; Sei Jin Chang
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

Review 7.  Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

8.  Gastric stromal tumors. Reappraisal of histogenesis.

Authors:  M T Mazur; H B Clark
Journal:  Am J Surg Pathol       Date:  1983-09       Impact factor: 6.394

9.  Accurately estimating breast cancer survival in Spain: cross-matching local cancer registries with the National Death Index.

Authors:  M Carmen Martos; Carme Saurina; Cristina Feja; Marc Saez; M Carmen Burriel; Maria Antònia Barceló; Pilar Gómez; Gemma Renart; Tomás Alcalá; Rafael Marcos-Gragera
Journal:  Rev Panam Salud Publica       Date:  2009-07

10.  Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study.

Authors:  Claudia Mucciarini; Giulio Rossi; Federica Bertolini; Riccardo Valli; Claudia Cirilli; Ivan Rashid; Luigi Marcheselli; Gabriele Luppi; Massimo Federico
Journal:  BMC Cancer       Date:  2007-12-20       Impact factor: 4.430

View more
  6 in total

1.  Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study.

Authors:  Jordi Rubió-Casadevall; Joan Lluis Borràs; Maria Carme Carmona-García; Alberto Ameijide; Allan Gonzalez-Vidal; Maria Rosa Ortiz; Ramon Bosch; Francesc Riu; David Parada; Esther Martí; Josefina Miró; Juan Jose Sirvent; Jaume Galceran; Rafael Marcos-Gragera
Journal:  World J Surg Oncol       Date:  2015-02-13       Impact factor: 2.754

2.  Peritonitis secondary to spontaneous perforation of a primary gastrointestinal stromal tumour of the small intestine: A case report and a literature review.

Authors:  Mario Alessiani; Marco Gianola; Sabina Rossi; Vittorio Perfetti; Piero Serra; Daniela Zelaschi; Enzo Magnani; Lorenzo Cobianchi
Journal:  Int J Surg Case Rep       Date:  2014-12-12

3.  Mesenteric fibromatosis after resection for gastrointestinal stromal tumor of stomach: A case report.

Authors:  Yiming Chu; Qingqu Guo; Dan Wu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

4.  Incidence, distribution of histological subtypes and primary sites of soft tissue sarcoma in China.

Authors:  Zhixun Yang; Rongshou Zheng; Siwei Zhang; Hongmei Zeng; He Li; Wanqing Chen
Journal:  Cancer Biol Med       Date:  2019-08       Impact factor: 4.248

5.  Incidence of gastrointestinal stromal tumor in Chinese urban population: A national population-based study.

Authors:  Lu Xu; Yanpeng Ma; Shengfeng Wang; Jingnan Feng; Lili Liu; Jinxi Wang; Guozhen Liu; Dianrong Xiu; Wei Fu; Siyan Zhan; Tao Sun; Pei Gao
Journal:  Cancer Med       Date:  2020-12-15       Impact factor: 4.452

6.  Population-based SEER trend analysis of overall and cancer-specific survival in 5138 patients with gastrointestinal stromal tumor.

Authors:  Ulrich Güller; Ignazio Tarantino; Thomas Cerny; Bruno M Schmied; Rene Warschkow
Journal:  BMC Cancer       Date:  2015-07-30       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.